Logo image of COO

COOPER COS INC/THE (COO) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:COO - US2166485019 - Common Stock

83.4001 USD
+0.27 (+0.32%)
Last: 1/9/2026, 3:22:07 PM

COO Key Statistics, Chart & Performance

Key Statistics
Market Cap16.58B
Revenue(TTM)4.09B
Net Income(TTM)374.90M
Shares198.81M
Float197.58M
52 Week High100.24
52 Week Low61.78
Yearly Dividend0
Dividend Yield0.02%
EPS(TTM)4.13
PE20.19
Fwd PE18.27
Earnings (Next)03-04 2026-03-04
IPO1983-01-21
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Supplies


COO short term performance overview.The bars show the price performance of COO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 5 10 15 20

COO long term performance overview.The bars show the price performance of COO in the last 1, 2 and 3 years. 1 year 2 years 3 years -2 -4 -6 -8 -10

The current stock price of COO is 83.4001 USD. In the past month the price increased by 5.88%. In the past year, price decreased by -7.95%.

COOPER COS INC/THE / COO Daily stock chart

COO Competitors/Peers

The largest stocks on the US markets in the "Health Care Supplies" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
SOLV SOLVENTUM CORP 14.47 14.90B
ALGN ALIGN TECHNOLOGY INC 17.83 12.37B
MMSI MERIT MEDICAL SYSTEMS INC 23.22 5.12B
LNTH LANTHEUS HOLDINGS INC 11.39 4.50B
HAE HAEMONETICS CORP/MASS 17.53 3.94B
ICUI ICU MEDICAL INC 19.05 3.74B
XRAY DENTSPLY SIRONA INC 8.09 2.55B
NEOG NEOGEN CORP 33.07 2.08B
UFPT UFP TECHNOLOGIES INC 29.89 1.99B
STAA STAAR SURGICAL CO N/A 1.10B
EMBC EMBECTA CORP 4.34 754.78M
BVS BIOVENTUS INC - A 13.54 661.25M

About COO

Company Profile

COO logo image The Cooper Cos, Inc. operates as a medical device company. The company is headquartered in San Ramon, California and currently employs 15,000 full-time employees. The firm operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. The company also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.

Company Info

COOPER COS INC/THE

6101 Bollinger Canyon Road, Suite 500

San Ramon CALIFORNIA 94583 US

CEO: Albert G. White III

Employees: 15000

COO Company Website

COO Investor Relations

Phone: 19254603600

COOPER COS INC/THE / COO FAQ

What does COOPER COS INC/THE do?

The Cooper Cos, Inc. operates as a medical device company. The company is headquartered in San Ramon, California and currently employs 15,000 full-time employees. The firm operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. The company also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.


What is the current price of COO stock?

The current stock price of COO is 83.4001 USD. The price increased by 0.32% in the last trading session.


Does COO stock pay dividends?

COOPER COS INC/THE (COO) has a dividend yield of 0.02%. The yearly dividend amount is currently 0.


What is the ChartMill rating of COOPER COS INC/THE stock?

COO has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Can you provide the sector and industry classification for COOPER COS INC/THE?

COOPER COS INC/THE (COO) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


What is the market capitalization of COO stock?

COOPER COS INC/THE (COO) has a market capitalization of 16.58B USD. This makes COO a Large Cap stock.


What is the outstanding short interest for COOPER COS INC/THE?

The outstanding short interest for COOPER COS INC/THE (COO) is 3.73% of its float.


COO Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to COO. When comparing the yearly performance of all stocks, COO turns out to be only a medium performer in the overall market: it outperformed 54.95% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

COO Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to COO. COO scores excellent on profitability, but there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

COO Financial Highlights

Over the last trailing twelve months COO reported a non-GAAP Earnings per Share(EPS) of 4.13. The EPS increased by 11.62% compared to the year before.


Industry RankSector Rank
PM (TTM) 9.16%
ROA 3.02%
ROE 4.55%
Debt/Equity 0.3
Chartmill High Growth Momentum
EPS Q2Q%10.58%
Sales Q2Q%4.6%
EPS 1Y (TTM)11.62%
Revenue 1Y (TTM)5.06%

COO Forecast & Estimates

24 analysts have analysed COO and the average price target is 91.89 USD. This implies a price increase of 10.18% is expected in the next year compared to the current price of 83.4001.

For the next year, analysts expect an EPS growth of 10.55% and a revenue growth 5.62% for COO


Analysts
Analysts75
Price Target91.89 (10.18%)
EPS Next Y10.55%
Revenue Next Year5.62%

COO Ownership

Ownership
Inst Owners106.05%
Ins Owners0.61%
Short Float %3.73%
Short Ratio2.63